Table 1

Base line characteristics of patients included into the RT-qPCR analysis of peripheral blood.

Venipuncture


A

B


Total number of patients

94

31


Breast cancer


Number

21

31


Age (yrs)


median

54

50


range

35-78

25-75


Histology


IDC

100.0%

64.5%


ILC

0

12.9%


Others/unknown

0

22.6%


TNM Stage *


I

38.1%

3.2%


II

33.3%

48.4%


III

23.8%

19.4%


IV

4.8%

3.2%


Unknown

0

22.6%


Endometrial cancer


Number

25

0


Age (yrs)


median

64


range

30-83


Histology


Endometrioid

100.0%


FIGO Stage


I

60.0%


II

8.0%


III

28.0%


IV

4.0%


Cervical Cancer


Number

25

0


Age (yrs)


median

48


range

29-78


Histology


Non-keratinizing

48.0%


Keratinizing

40.0%


Others/unknown

12.0%


FIGO Stage


I

8.0%


II

44.0%


III

28.0%


IV

20.0%


Ovarian cancer


Number

23

0


Age (yrs)


median

53


range

37-78


Histology


Serous

72.7%


Mucinous

12.1%


Others/unknown

15.1%


FIGO Stage


I

10.0%


II

10.0%


III

65.0%


IV

15.0%


Peripheral blood was taken from 94 patients before initial treatment of the primary tumor (A). From 31 recurrent breast cancer patients (B) the blood was taken during disease progression (* TNM stage refers to the primary tumor).

Obermayr et al. BMC Cancer 2010 10:666   doi:10.1186/1471-2407-10-666

Open Data